FGFR1 (R = 0.61, p < 0.0001; Figure 4C) is a member of the Fibroblast Growth Factor family whose alterations have been recently identified as likely mechanisms of primary and secondary resistance to therapy using anti-EGFR antibody in CRC [51]. Here, FGFR1 is linked to colorectal carcinoma.